Contributions of Positron Emission Tomography to elucidating the pathogenesis of Idiopathic Parkinsonism and Dopa Responsive Dystonia

  • D. B. Calne
  • R. de la Fuente-Fernández
  • A. Kishore
Part of the Journal of Neural Transmission. Supplementa book series (NEURAL SUPPL, volume 50)


The metabolic mapping of brain activity, using PET, confirms the conventional wisdom of neurophysiology. In studies of pathophysiology, PET has yielded evidence that has generated new hypotheses. Progression of the lesion detectable with fluorodopa, in human subjects exposed to MPTP, raises the possibility of a transient environmental event being a cause of progressive neurodegeneration. Studies with fluorodopa in Idiopathic Parkinsonism indicate that the rate of loss of neurons is faster initially, and then tends to approach the normal age-related decline. In dopa responsive dystonia, the finding of normal fluorodopa PET led to the prediction that the lesion would be functional rather than anatomical; this has been confirmed by the identification of a defect in dopamine synthesis in this disorder. Filally, new PET ligands show promise for future studies designed to unravel the pathogenesis of diseases involving the basal ganglia.


Positron Emission Tomography Idiopathic Parkinsonism Nigrostriatal System Raclopride Binding Dopa Responsive Dystonia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Brooks DJ (1993) Functional imaging in relation to parkinsonian syndrome. J Neurological Sci 115: 1–17CrossRefGoogle Scholar
  2. Brooks DJ, Ibanez V, Sawle G, et al (1992) Striatal D2 receptor status in patients with Parkinson’s disease striatonigral degeneration and progessive supranuclear palsy, measured with 11 C-Raclopride and positron emission tomography. Ann Neurol 31: 184–192PubMedCrossRefGoogle Scholar
  3. Calne DB, Nygaard TG, Snow BJ (1993) The distinction between early onset idiopathic parkinsonism (Juvenile Parkinson’s disease) and dopa-responsive-dystonia (hereditary progressive dystonia, Segawa dystonia). In: Segawa M (ed) Hereditary progressive dystonia with marked diurnal fluctuation. The Parthenon Publishing Group, Carnforth, UK, pp 215–218Google Scholar
  4. Eidelberg D, Moeller JR, Dhawan V, et al (1990) The metabolic anatomy of Parkinson’s disease: Complementary [18F] fluorodeoxyglucose and [18F] fluorodopa positron emission tomographic studies. Mov Disord 5: 203–213PubMedCrossRefGoogle Scholar
  5. Ichinose H, Ohye T, Takahashi E, et al (1994) Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GPT cyclohydrolase I gene. Nature Genetics 8: 236–242PubMedCrossRefGoogle Scholar
  6. Kishore A, Snow BJ, Naini AB, Przedborski S, Vingerhoets FJG, Nygaard TG (1995) Analysis of dopaminergic function in asymptomatic carriers of the DRD gene: CSF dopaminergic metabolites and PET with fluorodopa and raclopride. Neurology 45: A187 (Abstract)CrossRefGoogle Scholar
  7. Lee CS, Schulzer M, Mak EK, et al (1994) Clinical observations on the rate of progression of idiopathic parkinsonism. Brain 117: 501–507PubMedCrossRefGoogle Scholar
  8. Martin WRW, Beckman JH, Calne DB, et al (1984) Cerebral glucose metabolism in Parkinson’s disease. Can J Neurol Sci 11 [Suppl 1]: 169–173PubMedGoogle Scholar
  9. Otsuka M, Ichiya Y, Hosokawa S, et al (1991) Striatal blood flow, glucose metabolism and 18F-dopa uptake: Difference in Parkinson’s disease and atypical Parkinsonism. J Neurology, Neurosurgery, and Psychiatry 54: 898–904CrossRefGoogle Scholar
  10. Pate BD, Kawamata T, Yamada T, et al (1993) Correlation of striatal fluorodopa uptake in MPTP monkey with dopaminergic indices. Ann Neurol 34: 331–338PubMedCrossRefGoogle Scholar
  11. Peppard RF, Martin WRW, Clark CM, Carr GD, McGeer PL, Calne DB (1990) Cortical glucose metabolism in Parkinson’s and Alzheimer’s disease. J Neurosci Res 27: 561–568PubMedCrossRefGoogle Scholar
  12. Peppard RF, Martin WRW, Carr GD, et al (1993) Cerebral glucose metabolism in Parkinson’s disease with and without dementia. Arch Neurol 49: 1262–1268CrossRefGoogle Scholar
  13. Rajput AH, Gibb WRG, Zhong XH, et al (1994) Dopa-responsive dystonia: Pathological and biochemical observations in a case. Ann Neurol 35: 396–402PubMedCrossRefGoogle Scholar
  14. Rinne UK, Laihinen A, Rinne JO, Nagren K, Bergman J, Ruotsalainen U (1990) Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson’s disease. Mov Disord 5: 55–59PubMedCrossRefGoogle Scholar
  15. Sawle GV, Playford ED, Brooks DJ, Quinn N, Frackowiak SJ (1993) Asymmetrical presynaptic and post-synaptic changes in the striatal dopamine projection in dopa naive parkinsonism. Brain 116: 853–867PubMedCrossRefGoogle Scholar
  16. Schulzer M, Lee CS, Mak EK, Vingerhoets FJG, Calne DB (1994) A mathematical model of pathogenesis in idiopathic parkinsonism. Brain 117: 509–516PubMedCrossRefGoogle Scholar
  17. Shinotoh H, Hirayama K, Tateno Y (1993) Dopamine D1 and D2 receptors in Parkinson’s disease and striatonigral degeneration determined by PET. In: Narabayashi H, Nagatsu T, Yanagisawa N, Mizuno Y (eds) Parkinson’s disease from basic research to treatment, Advances in Neurology, vol 60. Raven Press, New York, pp 488–493Google Scholar
  18. Snow BJ, Tooyama I, McGeer EG, et al (1993a) Human positron emission tomographic [18F] fluorodopa studies correlate with dopamine cell counts and levels. Ann Neurol 34: 324–330PubMedCrossRefGoogle Scholar
  19. Snow B, Buckley K, Bailey D, et al (1993b) Dopamine-D2 receptor density is inversely correlated with dopaminergic innervation in untreated Parkinson’s disease. Neurology 43: A269Google Scholar
  20. Snow BJ, Nygaard TG, Takahashi H, Calne DB (1993c) Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism. Ann Neurol 34: 733–738PubMedCrossRefGoogle Scholar
  21. Wolfson LI, Leenders KL, Brown LL, Jones T (1985) Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson’s disease. Neurology 35: 1399PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 1997

Authors and Affiliations

  • D. B. Calne
    • 1
  • R. de la Fuente-Fernández
    • 1
  • A. Kishore
    • 1
  1. 1.Neurodegenerative Disorders Centre, Division of Neurology, Department of MedicineThe University of British Columbia, Vancouver Hospital and Health Sciences CentreVancouverCanada

Personalised recommendations